Bingjiao Yin

2.2k total citations
26 papers, 1.7k citations indexed

About

Bingjiao Yin is a scholar working on Immunology, Cancer Research and Molecular Biology. According to data from OpenAlex, Bingjiao Yin has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 10 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Bingjiao Yin's work include Immune Response and Inflammation (11 papers), NF-κB Signaling Pathways (9 papers) and Immune cells in cancer (7 papers). Bingjiao Yin is often cited by papers focused on Immune Response and Inflammation (11 papers), NF-κB Signaling Pathways (9 papers) and Immune cells in cancer (7 papers). Bingjiao Yin collaborates with scholars based in China, United States and Taiwan. Bingjiao Yin's co-authors include Shu‐Hsia Chen, Celia M. Divino, Ping‐Ying Pan, Zhuoya Li, Ge Ma, Junko Ozao‐Choy, Kaare J. Weber, George Wang, Hsun Teresa Ku and Junko Ozao and has published in prestigious journals such as Circulation, Blood and The Journal of Immunology.

In The Last Decade

Bingjiao Yin

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingjiao Yin China 18 1.1k 474 458 184 138 26 1.7k
Barry Ripley Japan 16 731 0.7× 378 0.8× 544 1.2× 241 1.3× 106 0.8× 24 1.5k
Halil‐Ibrahim Aksoylar United States 12 781 0.7× 301 0.6× 582 1.3× 181 1.0× 145 1.1× 19 1.3k
C. Christian Johansson Sweden 19 940 0.9× 590 1.2× 535 1.2× 171 0.9× 93 0.7× 29 1.7k
Anthos Christofides United States 10 879 0.8× 545 1.1× 663 1.4× 268 1.5× 111 0.8× 21 1.7k
Chaoming Mao China 20 758 0.7× 311 0.7× 454 1.0× 238 1.3× 131 0.9× 53 1.5k
Tung Chao Taiwan 9 805 0.7× 252 0.5× 604 1.3× 301 1.6× 198 1.4× 10 1.4k
Zsuzsanna Nagy United States 21 544 0.5× 285 0.6× 640 1.4× 168 0.9× 132 1.0× 41 1.3k
Juliane Lokau Germany 24 706 0.6× 717 1.5× 530 1.2× 153 0.8× 98 0.7× 55 1.5k
Taylor B. Guo China 18 663 0.6× 230 0.5× 460 1.0× 146 0.8× 130 0.9× 35 1.5k
Toshio Hirano Japan 9 715 0.6× 730 1.5× 584 1.3× 199 1.1× 113 0.8× 11 1.6k

Countries citing papers authored by Bingjiao Yin

Since Specialization
Citations

This map shows the geographic impact of Bingjiao Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingjiao Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingjiao Yin more than expected).

Fields of papers citing papers by Bingjiao Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingjiao Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingjiao Yin. The network helps show where Bingjiao Yin may publish in the future.

Co-authorship network of co-authors of Bingjiao Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Bingjiao Yin. A scholar is included among the top collaborators of Bingjiao Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingjiao Yin. Bingjiao Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ba, Hongping, Zunyue Zhang, Peng Zhang, et al.. (2023). Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers. Journal for ImmunoTherapy of Cancer. 11(1). e003837–e003837. 17 indexed citations
2.
Ba, Hongping, Rui Jiang, Meng Zhang, et al.. (2021). Suppression of Transmembrane Tumor Necrosis Factor Alpha Processing by a Specific Antibody Protects Against Colitis-Associated Cancer. Frontiers in Immunology. 12. 687874–687874. 6 indexed citations
3.
Miao, Kun, Ling Zhou, Hongping Ba, et al.. (2020). Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2. PLoS Biology. 18(12). e3000967–e3000967. 24 indexed citations
4.
Li, Chenxi, Mingxia Yu, Peng Yang, et al.. (2019). Inhibition of transmembrane TNF-α shedding by a specific antibody protects against septic shock. Cell Death and Disease. 10(8). 586–586. 15 indexed citations
5.
Zhou, Ling, Kun Miao, Bingjiao Yin, et al.. (2018). Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure. Circulation. 138(2). 181–197. 76 indexed citations
6.
Zhang, Zunyue, Guohong Lin, Xiang Li, et al.. (2018). Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells. Oncogene. 37(25). 3456–3470. 70 indexed citations
7.
Ba, Hongping, Xiaoyan Li, Cheng Li, et al.. (2017). Transmembrane tumor necrosis factor-α promotes the recruitment of MDSCs to tumor tissue by upregulating CXCR4 expression via TNFR2. International Immunopharmacology. 44. 143–152. 31 indexed citations
8.
Jiang, Yaping, Min Yu, Lu Han, et al.. (2017). STAT1 mediates transmembrane TNF-alpha-induced formation of death-inducing signaling complex and apoptotic signaling via TNFR1. Cell Death and Differentiation. 24(4). 660–671. 67 indexed citations
9.
Tu, Zhenbo, et al.. (2016). The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer. Oncotarget. 7(15). 20507–20519. 47 indexed citations
10.
Yang, Peng, Wenjing Zhou, Chenxi Li, et al.. (2015). Kupffer-cell-expressed transmembrane TNF-α is a major contributor to lipopolysaccharide and D-galactosamine-induced liver injury. Cell and Tissue Research. 363(2). 371–383. 41 indexed citations
11.
Yu, Mingxia, Guohong Lin, Jin Huang, et al.. (2013). Targeting Transmembrane TNF-α Suppresses Breast Cancer Growth. Cancer Research. 73(13). 4061–4074. 83 indexed citations
12.
Yin, Bingjiao, Xin Hu, Jing Wang, et al.. (2011). Blocking TNF-α by combination of TNF-α- and TNFR-binding cyclic peptide ameliorates the severity of TNBS-induced colitis in rats. European Journal of Pharmacology. 656(1-3). 119–124. 12 indexed citations
13.
Yin, Bingjiao, Ge Ma, Zuping Zhou, et al.. (2010). Myeloid-Derived Suppressor Cells Prevent Type 1 Diabetes in Murine Models. The Journal of Immunology. 185(10). 5828–5834. 145 indexed citations
14.
Pan, Ping‐Ying, Ge Ma, Kaare J. Weber, et al.. (2009). Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer. Cancer Research. 70(1). 99–108. 369 indexed citations
15.
Yu, Mingxia, Wenfang Shi, Jian Zhang, et al.. (2008). Influence of reverse signaling via membrane TNF-α on cytotoxicity of NK92 cells. European Journal of Cell Biology. 88(3). 181–191. 27 indexed citations
16.
Yan, Dan, Nalin Qin, Hailong Zhang, et al.. (2008). Expression of TNF-α leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNF-α. Breast Cancer Research and Treatment. 116(1). 91–102. 24 indexed citations
17.
Zhang, Hailong, Dan Yan, Xu Shi, et al.. (2008). Transmembrane TNF-α mediates “forward” and “reverse” signaling, inducing cell death or survival via the NF-κB pathway in Raji Burkitt lymphoma cells. Journal of Leukocyte Biology. 84(3). 789–797. 58 indexed citations
18.
Zhang, David, Josephine W. Wu, Fei Ye, et al.. (2005). Amplification of circularizable probes for the detection of target nucleic acids and proteins. Clinica Chimica Acta. 363(1-2). 61–70. 34 indexed citations
19.
Shi, Wenfang, Bingjiao Yin, Ping Xiong, Feili Gong, & Zhuoya Li. (2004). [Relationship between cytotoxicity of two types of TNF-alpha and intracellular free calcium concentration in target cells].. PubMed. 20(5). 537–9. 1 indexed citations
20.
Li, Zhuoya, et al.. (2002). The expression and activity of human soluble TNF receptor I by E. coli and appraisement of its activity. 18(11). 743–746. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry Ripley Breakdown of academic impact, for papers by Halil‐Ibrahim Aksoylar Breakdown of academic impact, for papers by C. Christian Johansson Breakdown of academic impact, for papers by Anthos Christofides Breakdown of academic impact, for papers by Chaoming Mao Breakdown of academic impact, for papers by Tung Chao Breakdown of academic impact, for papers by Zsuzsanna Nagy Breakdown of academic impact, for papers by Juliane Lokau Breakdown of academic impact, for papers by Taylor B. Guo Breakdown of academic impact, for papers by Toshio Hirano
Rankless by CCL
2026